Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: Relationship with corticosteroid dosage, renal function, sex, and patient age

Transplantation Proceedings

Volumn 31, Issue 6, 1999, Pages 2270-2271

  Puig, J M ^a   Fernandez Crespo P ^a   Lloveras, J ^a   Mir, M ^a   Inigo V ^a   Manresa, J M ^a   Masramon J ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGE; ANEMIA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; CREATININE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; PROTEINURIA; RENAL DIALYSIS; REOPERATION; RISK FACTORS;

EID: 0345062246     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00333-4     Document Type: Conference Paper

References (4)

1. Allison A.C., Kowalsky W.J., Muller C.J., et al. Transplant Proc. 25:(3 suppl 2):1993;67.
2. Lindholm A., Ohlman S., Albrechtson D., et al. Transplantation. 56:1993;307.
3. Sollinger H.W. US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. 60:1995;225.
4. Keown P.A. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation. 61:1996;1029.